Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Medivive vs MEDVidi

Medivive
Graded #335

Higher grade

vs+1.7000000000000028
MEDVidi
Graded #384

Lower grade

The verdict

Medivive takes it — 59.7/100 to 58/100, but only just.

Medivive grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Medivive is a US telehealth service offering compounded semaglutide and tirzepatide for weight loss, filled through a licensed pharmacy, with providers licensed in all 50 states and no insurance required. MEDVidi is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMedivive +26
71
45
Dose & formulationMEDVidi +13
40
53
Clinical oversightMEDVidi +14
63
77
Labs & monitoringMedivive +2
64
62
FulfillmentMedivive +2
61
59
Contract termsEven
55
55
Medivive · left barMEDVidi · right bar

The numbers

MetricMediviveMEDVidi
WeighScore59.7/10058/100
GradeCC
Scorecard rank#335#384
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Medivive

Graded #335 · C

Strengths

  • Compounded semaglutide and tirzepatide with providers licensed in all 50 states
  • No insurance required; one-stop for GLP-1 plus TRT, NAD+ and longevity care
  • Medication filled through a licensed pharmacy

Where it loses points

  • Monthly pricing not published; disclosed only after an AI intake
  • No legal entity or named pharmacy disclosed
  • Service states are not individually listed
MEDVidi

Graded #384 · C

Strengths

  • Licensed providers can prescribe brand-name Zepbound and Wegovy
  • Transparent flat consultation fees (195 dollar initial, 159 dollar follow-up)
  • Prescriptions sent to the patient's pharmacy of choice, so insurance can be used

Where it loses points

  • Consult-fee model: medication is not included and its cost is separate
  • No medication pricing is published
  • State list is shown as a map rather than enumerated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard